CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-04 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option(right to buy) | +175,000 | 175,000 | ||
| 2018-01-04 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option(right to buy) | +437,500 | 437,500 | ||
| 2017-11-16 | Panayiotopoulos Paris Director | Purchase | +14,285 | $7.03 | $100K | 14,285 |
| 2017-11-15 | Hochman David P Director | Purchase | +5,000 | $6.55 | $33K | 220,000 |
| 2017-11-13 | Hochman David P Director | Purchase | +5,000 | $6.90 | $35K | 215,000 |
| 2017-11-13 | Hochman David P Director | Grant or award | +5,000 | $6.90 | $35K | 215,000 |
| 2017-11-10 | Moran Sean F. Chief Financial Officer | Purchase | +1,500 | $7.04 | $11K | 340,910 |
| 2017-11-10 | White Barbara Chief Medical Officer | Purchase | +2,836 | $7.00 | $20K | 174,050 |
| 2017-11-10 | Hochman David P Director | Purchase | +10,000 | $7.08 | $71K | 459,500 |
| 2017-11-10 | Cohen Yuval Chief Executive Officer | Purchase | +1,000 | $7.17 | $7K | 58,775 |
| 2017-10-16 | Panayiotopoulos Paris Director | Grant or award · Stock Option(right to buy) | +61,000 | 61,000 | ||
| 2017-08-11 | White Barbara Chief Medical Officer | Purchase | +2,479 | $6.05 | $15K | 171,214 |
| 2017-08-11 | Cohen Yuval Chief Executive Officer | Purchase | +1,695 | $6.00 | $10K | 57,775 |
| 2017-08-11 | Moran Sean F. Chief Financial Officer | Purchase | +2,500 | $5.91 | $15K | 339,410 |
| 2017-05-25 | GUPTA RENU Director | Grant or award · Stock Option(right to buy) | +30,500 | 30,500 | ||
| 2017-05-25 | CATLIN AVERY W Director | Grant or award · Stock Option(right to buy) | +30,500 | 30,500 | ||
| 2017-05-25 | HOLMER ALAN F Director | Grant or award · Stock Option(right to buy) | +30,500 | 30,500 | ||
| 2017-05-25 | Hochman David P Director | Grant or award · Stock Option(right to buy) | +30,500 | 30,500 | ||
| 2017-05-11 | Moran Sean F. Chief Financial Officer | Purchase | +3,300 | $6.14 | $20K | 336,910 |
| 2017-05-11 | HOLMER ALAN F Director | Purchase | +500 | $6.23 | $3K | 22,500 |
Page 16 of 16 · 320 trades